Interestingly, its high sensitivity for striated muscle damage is illustrated by its evolving role as an accepted novel biomarker for peripheral arterial disease, where repetitive tissue ischemia and reperfusion lead to an acquired myopathy with FABP3 elevation [48]. Here, FABP3 is linked to peripheral arterial disease.